It's that the metabolic pathway it disrupts is the same pathway endurance performance depends on
A review of neurobiological mechanisms in nerve degeneration and regeneration, including nerve compression and more severe nerve injuries, in healthy people and people with diabetes
Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes. Despite promising results from existing randomized controlled trials of semaglutide and tirzepatide in those with obesity-related HFpEF, regulatory authorities and professional societies have not approved or endorsed the use of these drugs for HFpEF, due in part to the studies relatively small sample sizes and unknown generalizability
You feel satisfied longer, with the added bonus of improved insulin balance
Quick answer Sermorelin is an educational research profile for people comparing mechanism, potential benefits, evidence strength, and related compounds in growth & performance
In short: semaglutide is a trusted and proven single-pathway option, while tirzepatide offers amplified effects through a dual mechanism